ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Approved Clinical Trials

May 28, 2010

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

City of Hope CEO Michael Friedman: Cancer Centers Must Adapt; “Not Losing Sleep” Over Sequestration

April 5, 2013

NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division

May 12, 1989

8 Centers Awarded Comprehensive Designation

February 15, 1991

In Brief: Sabin Leaves Frederick For So. Carolina; Georgia Worried Over Missing Out On Comprehensive Center

October 11, 1974